Myosana Therapeutics
Latest round
- Seed
Last raised
- Nov 2022
Total raised
- $6.4M
Investors
- 3
About Myosana Therapeutics
Myosana Therapeutics, founded in 2018 in Seattle, US, specializes in innovative gene therapies.Myosana Therapeutics specializes in developing a targeted non-viral gene therapy platform aimed at addressing neuromuscular and cardiac genetic diseases. Their core product offerings include innovative gene therapies designed to treat conditions such as Duchenne muscular dystrophy (DMD) and X-linked myotubular myopathy (MTM). The Myosana platform is engineered to overcome the inherent limitations of viral delivery methods, allowing for a broader range of genetic diseases to be treated. The end users of these therapies are primarily patients suffering from severe genetic disorders characterized by muscle degeneration and cardiac complications. The company is focused on expanding its product pipeline, aiming to enhance its offerings for treating genetic disorders. Plans for geographic expansion include targeting markets in Europe by the end of 2024, as they develop strategic partnerships to facilitate entry into these regions.
Who invested in Myosana Therapeutics
3 investors across 1 round
See all investors in Myosana Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 22, 2022
Amount
$6.4M
Investors
Questions about Myosana Therapeutics
Who invested in Myosana Therapeutics?
Myosana Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myosana Therapeutics raised?
Myosana Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Myosana Therapeutics last raise money?
Myosana Therapeutics's most recent round on record is a Seed, in Nov 2022.
What does Myosana Therapeutics do?
Myosana Therapeutics, founded in 2018 in Seattle, US, specializes in innovative gene therapies.
Where is Myosana Therapeutics headquartered?
Myosana Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Myosana Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Myosana Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Myosana Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.